Le Lézard
Classified in: Health, Covid-19 virus
Subjects: PSF, CMG

COVID-19 - State of emergency renewed for the urban agglomeration of Montréal


MONTRÉAL, Aug. 18, 2021 /CNW Telbec/ - In accordance with the Civil Protection Act, Montréal's executive committee has renewed the state of emergency for the urban agglomeration of Montréal on August 18, for a period of five days.  

The local state of emergency, which was declared on March 27, 2020, grants exceptional powers to the urban agglomeration, enabling it to respond to the current pandemic across its territory. In particular, it gives the urban agglomeration the power to mobilize the necessary resources and workforce to fight COVID-19. 

The urban agglomeration of Montréal continues to collaborate closely with its team of experts from its emergency response coordination centre, the regional public health department and the healthcare and social services network, in order to fight the spread of COVID-19. 

Read more: Civil Protection Act

Montréal's Web portal: montreal.ca

SOURCE Ville de Montréal


These press releases may also interest you

at 16:32
The wishes that Make-A-Wish grants wouldn't be possible without the support of countless "WishMakers" such as donors, volunteers, corporate partners, community advocates and more. "WishMakers" ? a term for anyone who steps up to take action...

at 16:30
Today, the Honourable Ya'ara Saks, Minister of Mental Health and Addictions and Associate Minister of Health, announced a new appointment to the Canadian Centre on Substance Use and Addiction (CCSA) Board of Directors. Scott Elliott is appointed as...

at 16:28
The Rett Syndrome Research Trust (RSRT) is proud to announce its partnership with PMD Solutions, a leading provider of innovative healthcare technologies, in their upcoming biosensor validation study called VIBRANT. PMD Solutions will generously...

at 16:20
Pulse Biosciences, Inc. , a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablationtm (nsPFAtm) technology, today announced business updates and financial results for the fourth quarter and full year ended December 31,...

at 16:20
AN2 Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on developing treatments for rare, chronic, and serious infectious diseases with high unmet needs, today reported financial results for the fourth quarter and year ended...

at 16:20
Pulse Biosciences, Inc. , a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablationtm (nsPFAtm) technology, today announced that its Board of Directors has unanimously approved plans to initiate a rights offering. The...



News published on and distributed by: